182 related articles for article (PubMed ID: 17010412)
1. Surface-dependent expression in the platelet GPIb binding domain within human von Willebrand factor studied by atomic force microscopy.
Kang I; Raghavachari M; Hofmann CM; Marchant RE
Thromb Res; 2007; 119(6):731-40. PubMed ID: 17010412
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
[TBL] [Abstract][Full Text] [Related]
3. Structure-function relationship of the A1 domain of von Willebrand factor.
Girma JP; Ribba AS; Meyer D
Thromb Haemost; 1995 Jul; 74(1):156-60. PubMed ID: 8578449
[TBL] [Abstract][Full Text] [Related]
4. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation.
Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS
Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340
[TBL] [Abstract][Full Text] [Related]
5. Protamine sulphate inhibits platelet membrane glycoprotein Ib-von Willebrand factor activity.
Barstad RM; Stephens RW; Hamers MJ; Sakariassen KS
Thromb Haemost; 2000 Feb; 83(2):334-7. PubMed ID: 10739395
[TBL] [Abstract][Full Text] [Related]
6. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
Caron C; Hilbert L; Vanhoorelbeke K; Deckmyn H; Goudemand J; Mazurier C
Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443
[TBL] [Abstract][Full Text] [Related]
7. Flow-based measurements of von Willebrand factor (VWF) function: binding to collagen and platelet adhesion under physiological shear rate.
Fuchs B; Budde U; Schulz A; Kessler CM; Fisseau C; Kannicht C
Thromb Res; 2010 Mar; 125(3):239-45. PubMed ID: 19853893
[TBL] [Abstract][Full Text] [Related]
8. Interactions of human von Willebrand factor with a hydrophobic self-assembled monolayer studied by atomic force microscopy.
Siedlecki CA; Eppell SJ; Marchant RE
J Biomed Mater Res; 1994 Sep; 28(9):971-80. PubMed ID: 7814438
[TBL] [Abstract][Full Text] [Related]
9. Defect of heparin binding in plasma and recombinant von Willebrand factor with type 2 von Willebrand disease mutations.
Rastegar-Lari G; Ajzenberg N; Ribba AS; Vereycken-Holler V; Legendre P; Villoutreix B; Meyer D; Baruch D
Thromb Haemost; 2001 Dec; 86(6):1459-65. PubMed ID: 11776314
[TBL] [Abstract][Full Text] [Related]
10. A template-assembled synthetic protein surface mimetic of the von Willebrand factor A1 domain inhibits botrocetin-induced platelet aggregation.
Hauert J; Fernandez-Carneado J; Michielin O; Mathieu S; Grell D; Schapira M; Spertini O; Mutter M; Tuchscherer G; Kovacsovics T
Chembiochem; 2004 Jun; 5(6):856-64. PubMed ID: 15174170
[TBL] [Abstract][Full Text] [Related]
11. O-linked glycosylation and functional incompatibility of porcine von Willebrand factor for human platelet GPIb receptors.
Schulte Am Esch J; Robson SC; Knoefel WT; Hosch SB; Rogiers X
Xenotransplantation; 2005 Jan; 12(1):30-7. PubMed ID: 15598271
[TBL] [Abstract][Full Text] [Related]
12. Simulation of platelet adhesion and aggregation regulated by fibrinogen and von Willebrand factor.
Mori D; Yano K; Tsubota K; Ishikawa T; Wada S; Yamaguchi T
Thromb Haemost; 2008 Jan; 99(1):108-15. PubMed ID: 18217141
[TBL] [Abstract][Full Text] [Related]
13. [Determination of the detachment force of platelet membrane protein GPIb/IX and von Willebrand factor].
Wang Y; Gao Z; Hu Y; Hu Q; Yang C; Zhuang F
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Jun; 26(3):590-4, 605. PubMed ID: 19634679
[TBL] [Abstract][Full Text] [Related]
14. Distinct role of von Willebrand factor triplet bands in glycoprotein Ib-dependent platelet adhesion and thrombus formation under flow.
Fuchs B; de Witt S; Solecka BA; Kröning M; Obser T; Cosemans JM; Schneppenheim R; Heemskerk JW; Kannicht C
Semin Thromb Hemost; 2013 Apr; 39(3):306-14. PubMed ID: 23378253
[TBL] [Abstract][Full Text] [Related]
15. Interaction of the von Willebrand factor with platelets and thrombosis.
Perutelli P; Mori PG
Recenti Prog Med; 1997 Nov; 88(11):526-9. PubMed ID: 9401429
[TBL] [Abstract][Full Text] [Related]
16. Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain.
Huizinga EG; Tsuji S; Romijn RA; Schiphorst ME; de Groot PG; Sixma JJ; Gros P
Science; 2002 Aug; 297(5584):1176-9. PubMed ID: 12183630
[TBL] [Abstract][Full Text] [Related]
17. Impact of O-linked glycosylation of the VWF-A1-domain flanking regions on platelet interaction.
Schulte am Esch J; Robson SC; Knoefel WT; Eisenberger CF; Peiper M; Rogiers X
Br J Haematol; 2005 Jan; 128(1):82-90. PubMed ID: 15606553
[TBL] [Abstract][Full Text] [Related]
18. Molecular modeling of the seven tandem leucine-rich repeats within the ligand-binding region of platelet glycoprotein Ib alpha.
Whisstock JC; Shen Y; López JA; Andrews RK; Berndt MC
Thromb Haemost; 2002 Feb; 87(2):329-33. PubMed ID: 11858495
[TBL] [Abstract][Full Text] [Related]
19. Biomedicine. Contact--how platelets touch von Willebrand factor.
Sadler JE
Science; 2002 Aug; 297(5584):1128-9. PubMed ID: 12183613
[No Abstract] [Full Text] [Related]
20. Evidence from limited proteolysis of a ristocetin-induced conformational change in human von Willebrand factor that promotes its binding to platelet glycoprotein Ib-IX-V.
Kang M; Wilson L; Kermode JC
Blood Cells Mol Dis; 2008; 40(3):433-43. PubMed ID: 17977030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
